William Blair analyst Jake Roberge has maintained their bullish stance on VERX stock, giving a Buy rating today. Jake Roberge has given his Buy rating due to a combination of factors including ...
Bradley Sills, an analyst from Bank of America Securities, reiterated the Hold rating on Vertex (VERX – Research Report). The associated price target was raised to $40.00. Bradley Sills has given his ...
Zacks Investment Research on MSN
Vertex Pharmaceuticals Incorporated (VRTX) is attracting investor attention: Here is what you should know
Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Vertex Pharmaceuticals Incorporated's stock has shown resilience, recovering from dips and maintaining a strong long-term growth trajectory, driven by its robust CF franchise and new product approvals ...
Vertex Pharmaceuticals reported decent Q1 earnings, but the company missed estimates for both revenue and earnings. Vertex's diversification efforts are most visible in the progress of its pain ...
In the webinar organized by pv magazine, the representatives talked of the quality, reliability and performance of Trina Solar’s Vertex N modules. These modules have passed numerous extended ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Vertex Minerals Ltd. announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback